Tuberculosis Treatment News and Information

What is Tuberculosis? (Definition)

Tuberculosis (TB) is a disease brought on by bacteria called Mycobacterium tuberculosis. These bacteria usually attack the lungs, but they can also damage other parts of the body including kidneys, spine and brain. Not everyone infected with TB bacteria becomes sick. As a result, two Tuberculosis-related conditions exist: latent TB infection (LTBI) and TB disease. If not treated properly, TB disease can be fatal. Tuberculosis is spread through the air by people who have active TB in their lungs through coughing, speaking, or sneezing. These disease is spread when people nearby inhale the bacteria.

 

Signs and Symptoms of Tuberculosis:

According to the U.S. Department of Health and Human Services, symptoms of TB in the lungs may include

  • A bad cough that lasts 3 weeks or longer
  • Weight loss
  • Loss of appetite
  • Coughing up blood or mucus
  • Weakness or fatigue
  • Fever
  • Night sweats

See below for updated news and information regarding Tuberculosis including new medical research, treatment options and advancements. 

Latest Tuberculosis Treatment News and Research

Tuberculosis Treatment News: Cleverly designed tuberculosis vaccine shows promise in mice

(SOURCE: AMERICAN SOCIETY FOR MICROBIOLOGY) - A clever new tuberculosis vaccine has shown promise in trials in mice. If it succeeds, it will be the first new TB vaccine in a century. With the rise of multidrug resistant tuberculosis, the difficulty of curing the disease, and the large annual death toll, a successful vaccine could be a huge benefit to public ...
Read More

Tuberculosis Treatment News: REDUCING DRUG DOSAGE, AND HEARING LOSS IN TB PATIENTS WITHOUT REDUCING EFFICACY

(SOURCE: AMERICAN SOCIETY FOR MICROBIOLOGY) - Aminoglycosides, recommended by the World Health Organization to treat multidrug resistant tuberculosis, cause hearing loss and kidney damage in a dose dependent manner. Now, by reducing the dose in a carefully calculated fashion, Dutch clinician researchers have been able to greatly reduce the numbers of patients suffering hearing loss, without compromising effectiveness against tuberculosis. The research ...
Read More

Tuberculosis Treatment News: NIH-Supported Scientists Accelerate Immune Response to Tuberculosis in Mice

(SOURCE: NIH/NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES) - Findings Could Lead to Improved TB Vaccines for Humans. New research findings provide insight into the immune system pathways that may be key to developing an effective tuberculosis (TB) vaccine. The study, to be published Thursday in the journal Nature Communications, was supported by the National Institute of Allergy and Infectious Diseases (NIAID), ...
Read More

Tuberculosis Research News: Ancient Chinese malaria remedy fights TB

(SOURCE: MICHIGAN STATE UNIVERSITY) - A centuries-old herbal medicine, discovered by Chinese scientists and used to effectively treat malaria, has been found to potentially aid in the treatment of tuberculosis and may slow the evolution of drug resistance. In a promising study led by Robert Abramovitch, a Michigan State University microbiologist and TB expert, the ancient remedy artemisinin stopped the ability of ...
Read More

Tuberculosis Research News: Computer Model Predicts Potential Impact of Short-Course Therapy Against Multidrug-Resistant Tuberculosis

(SOURCE: JOHNS HOPKINS MEDICINE) - Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially reduce the global incidence and spread of the disease. The computer model was developed to help understand the impact of a recommendation issued in May by the World Health Organization for wider use ...
Read More

Tuberculosis Treatment News: A Promising New Form of Treatment May be Within Reach

(AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS) According to a recent press release, Tuberculosis (TB) is responsible for more than 1.8 million deaths each year, according to the World Health Organization, yet there has been little significant improvement in therapies in the past 20 years. This chronic disease is systemic, meaning it affects not only the lungs but also other organs, such ...
Read More

Research at Johns Hopkins Targets Tuberculosis

(JOHNS HOPKINS MEDICINE) According to a recent press release, researchers at Johns Hopkins report they have laid the foundation to develop novel antibiotics that work against incurable, antibiotic-resistant bacteria like tuberculosis by targeting an enzyme essential to the production and integrity of bacterial cell walls ...
Read More